Presentation is loading. Please wait.

Presentation is loading. Please wait.

Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label,

Published byLuiz Eduardo Carvalhal Campelo Modified over 6 years ago

Similar presentations

Presentation on theme: "Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label,"— Presentation transcript:

1 Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial  Prof Beatriz Grinsztejn, PhD, Nathalie De Castro, MD, Vincent Arnold, PhD, Prof Valdiléa G Veloso, PhD, Prof Mariza Morgado, PhD, José Henrique Pilotto, PhD, Prof Carlos Brites, PhD, José Valdez Madruga, MSc, Nêmora Tregnago Barcellos, PhD, Breno Riegel Santos, MD, Carla Vorsatz, MD, Catherine Fagard, MD, Marilia Santini-Oliveira, PhD, Olivier Patey, MD, Constance Delaugerre, PhD, Prof Geneviève Chêne, PhD, Prof Jean-Michel Molina, MD  The Lancet Infectious Diseases  Volume 14, Issue 6, Pages (June 2014) DOI: /S (14)70711-X Copyright © 2014 Elsevier Ltd Terms and Conditions

2 Figure 1 Trial profile The Lancet Infectious Diseases  , DOI: ( /S (14)70711-X) Copyright © 2014 Elsevier Ltd Terms and Conditions

3 Figure 2 Virological response Error bars are 95% CIs.
The Lancet Infectious Diseases  , DOI: ( /S (14)70711-X) Copyright © 2014 Elsevier Ltd Terms and Conditions

Download ppt "Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label,"

Similar presentations

A randomized trial to estimate efficacy and safety of 2 doses of raltegravir and efavirenz for treatment of HIV-TB co-infected patients : ANRS 12 180 REFLATE.

A randomized trial to estimate efficacy and safety of 2 doses of raltegravir and efavirenz for treatment of HIV-TB co-infected patients : ANRS REFLATE.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages 1590-1605 (November 2012) DOI: 10.1016/S0140-6736(12)60026-9.

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 14, Issue 4, Pages (April 2013)

Volume 14, Issue 4, Pages (April 2013)
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration  Alasdair Reid, MD, Fabio Scano,

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration  Alasdair Reid, MD, Fabio Scano,
Enhanced performance feedback and patient participation to improve hand hygiene compliance of health-care workers in the setting of established multimodal.

Enhanced performance feedback and patient participation to improve hand hygiene compliance of health-care workers in the setting of established multimodal.
Volume 379, Issue 9824, Pages (April 2012)

Volume 379, Issue 9824, Pages (April 2012)
Volume 357, Issue 9273, Pages (June 2001)

Volume 357, Issue 9273, Pages (June 2001)
BMI and risk of dementia in two million people over two decades: a retrospective cohort study  Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.

BMI and risk of dementia in two million people over two decades: a retrospective cohort study  Dr Nawab Qizilbash, MRCP, John Gregson, PhD, Michelle E.
Volume 367, Issue 9517, Pages (April 2006)

Volume 367, Issue 9517, Pages (April 2006)
Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled.

Surgery versus conservative management for recurrent and ongoing left-sided diverticulitis (DIRECT trial): an open-label, multicentre, randomised controlled.
Volume 357, Issue 9257, Pages (March 2001)

Volume 357, Issue 9257, Pages (March 2001)
Volume 359, Issue 9322, Pages (June 2002)

Volume 359, Issue 9322, Pages (June 2002)
Pharmacogenetics and future drug development and delivery

Pharmacogenetics and future drug development and delivery
Volume 11, Issue 4, Pages (April 2012)

Volume 11, Issue 4, Pages (April 2012)
Urine antigen test for diagnosis of HIV-associated tuberculosis

Urine antigen test for diagnosis of HIV-associated tuberculosis
Volume 376, Issue 9734, Pages (July 2010)

Volume 376, Issue 9734, Pages (July 2010)
Long-term effects of hormone replacement therapy

Long-term effects of hormone replacement therapy
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 14, Issue 4, Pages (April 2013)

Volume 14, Issue 4, Pages (April 2013)
Volume 373, Issue 9666, Pages (March 2009)

Volume 373, Issue 9666, Pages (March 2009)

Similar presentations

Ads by Google